Literature DB >> 8392338

Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II.

D A Burden1, L J Goldsmith, D M Sullivan.   

Abstract

Cell-cycle-dependent protein levels and phosphorylation of DNA topoisomerase II in relation to its catalytic and cleavage activities were studied in Chinese-hamster ovary cells. Immunoreactive topoisomerase II protein levels were maximal in G2-phase cells, intermediate in S- and M-phase cells, and minimal in a predominantly G1-phase population. When the phosphorylation of topoisomerase II in vivo was corrected for differences in specific radioactivity of intracellular ATP, the apparent phosphorylation of S- and M-phase topoisomerase II was altered significantly. Relative phosphorylation in vivo was found to be greatest in M-phase cells and decreased in the other populations in the order: S > G2 > asynchronous. Phosphoserine was detected in every phase of the cell cycle, with a minor contribution of phosphothreonine demonstrated in M-phase cells. Topoisomerase II activity measured in vivo as 9-(4,6-O-ethylidene-beta-D-glucopyranosyl)-4'-demethylepipodophylloto xin (VP-16)-induced DNA double-strand breaks (determined by neutral filter elution) increased in the order: asynchronous < S < G2 < M. Topoisomerase II cleavage activity, assayed in vitro as the formation of covalent enzyme-DNA complexes, was lowest in S phase, intermediate in asynchronous and G2-phase cells, and maximal in M phase. Topoisomerase II decatenation activity was 1.6-1.8-fold greater in S-, G2- and M-phase populations relative to asynchronous cells. Therefore DNA topoisomerase II activity measured both in vivo and in vitro is maximal in M phase, that phase of the cell cycle with an intermediate level of immunoreactive topoisomerase II but the highest level of enzyme phosphorylation. The discordance between immunoreactive topoisomerase II protein levels, adjusted relative phosphorylation, catalytic activity, cleavage activity and amino acid residue(s) modified, suggests that the site of phosphorylation may be cell-cycle-dependent and critical in determining catalytic and cleavage activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392338      PMCID: PMC1134354          DOI: 10.1042/bj2930297

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line.

Authors:  D M Sullivan; M D Latham; T C Rowe; W E Ross
Journal:  Biochemistry       Date:  1989-06-27       Impact factor: 3.162

2.  Evidence that a protein kinase enhances amsacrine mediated formation of topoisomerase II-DNA complexes in murine mastocytoma cell nuclei.

Authors:  S J Darkin-Rattray; R K Ralph
Journal:  Biochim Biophys Acta       Date:  1991-02-16

3.  Phosphorylation of DNA topoisomerase II in a human tumor cell line.

Authors:  D J Kroll; T C Rowe
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

Review 4.  DNA repair in radiation sensitive mutants of mammalian cells: possible involvement of DNA topoisomerases.

Authors:  I D Hickson; S L Davies; S M Davies; C N Robson
Journal:  Int J Radiat Biol       Date:  1990-10       Impact factor: 2.694

5.  Segregation of recombined chromosomes in meiosis I requires DNA topoisomerase II.

Authors:  D Rose; W Thomas; C Holm
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

6.  Age-dependent increase of DNA topoisomerase II activity in quail oviduct; modulation of the nuclear matrix-associated enzyme activity by protein phosphorylation and poly(ADP-ribosyl)ation.

Authors:  H C Schröder; R Steffen; R Wenger; D Ugarković; W E Müller
Journal:  Mutat Res       Date:  1989 Sep-Nov       Impact factor: 2.433

7.  Alteration of DNA topoisomerase II activity during infection of H9 cells by human immunodeficiency virus type 1 in vitro: a target for potential therapeutic agents.

Authors:  E Matthes; P Langen; H Brachwitz; H C Schröder; A Maidhof; B E Weiler; K Renneisen; W E Müller
Journal:  Antiviral Res       Date:  1990-06       Impact factor: 5.970

8.  Purification and characterization of type II DNA topoisomerase from mouse FM3A cells: phosphorylation of topoisomerase II and modification of its activity.

Authors:  M Saijo; T Enomoto; F Hanaoka; M Ui
Journal:  Biochemistry       Date:  1990-01-16       Impact factor: 3.162

9.  Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.

Authors:  M J Robinson; N Osheroff
Journal:  Biochemistry       Date:  1990-03-13       Impact factor: 3.162

10.  Topoisomerase II is a structural component of mitotic chromosome scaffolds.

Authors:  W C Earnshaw; B Halligan; C A Cooke; M M Heck; L F Liu
Journal:  J Cell Biol       Date:  1985-05       Impact factor: 10.539

View more
  6 in total

Review 1.  Structure and function of type II DNA topoisomerases.

Authors:  P M Watt; I D Hickson
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

2.  Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae.

Authors:  S Jensen; A H Andersen; E Kjeldsen; H Biersack; E H Olsen; T B Andersen; O Westergaard; B K Jakobsen
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

3.  The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.

Authors:  P R Caron; P Watt; J C Wang
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

4.  Mitotic phosphorylation stimulates DNA relaxation activity of human topoisomerase I.

Authors:  Jennifer S Hackbarth; Marina Galvez-Peralta; Nga T Dai; David A Loegering; Kevin L Peterson; Xue W Meng; Larry M Karnitz; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

5.  Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.

Authors:  Adrian G Grozav; Kenichi Chikamori; Toshiyuki Kozuki; Dale R Grabowski; Ronald M Bukowski; Belinda Willard; Michael Kinter; Anni H Andersen; Ram Ganapathi; Mahrukh K Ganapathi
Journal:  Nucleic Acids Res       Date:  2008-11-29       Impact factor: 16.971

6.  Mechanisms regulating resistance to inhibitors of topoisomerase II.

Authors:  Ram N Ganapathi; Mahrukh K Ganapathi
Journal:  Front Pharmacol       Date:  2013-08-01       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.